Professor Ashok Venkitaraman, Ursula Zoellner Professor; Director, MRC Cancer Cell Unit
Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.
Professor Duncan Jodrell, DM MSc FRCP(Edin.) – Co Director, Researcher and Medical Oncologist
Duncan is the Professor of Cancer Therapeutics at the University of Cambridge and a Senior Group Leader at the Cancer Research UK Cambridge Institute. He is also the Cambridge Experimental Cancer Medicine Centre (ECMC) Lead, Director of the Cambridge Cancer Trials Centre (CCTC) and an honorary consultant at Addenbrooke’s Hospital
Dr Martin L Miller MSc PhD
Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.
Dr. Giulia Biffi
Giulia Biffi is a group leader at the Cancer Research UK Cambridge Institute, University of Cambridge. Her laboratory works to understand the biology of pancreatic cancer, with aim of identifying more effective treatments for patients.
Dr. Frances Richards
Frances Richards is the Pharmacology & Drug Development Group (Jodrell Group) Lab Head in the Cancer Research UK Cambridge Institute. With a background in cancer genetics and in drug discovery, she leads research projects focussed on preclinical development of drug combinations for treatment of pancreatic cancer.